Treatment of neurotic disorders

Abstract

Use of escitalopram (the S-(+)-enantiomer of citalopram) or a pharmaceutically acceptable salt thereof for the preparation of a medicament useful in the treatment of neurotic disorders is provided, including anxiety states, in particular generalized anxiety disorder and social anxiety disorder, post traumatic stress disorder, obsessive compulsive disorder and panic attacks.

1 - 14 . (canceled)  
   
   
       15 . A method of treating obsessive compulsive disorder in a patient in need thereof comprising administration of a pharmaceutically effective amount of escitalopram or a pharmaceutically acceptable salt thereof to the patient.  
   
   
       16 . The method of  claim 15 , wherein the escitalopram or a pharmaceutically acceptable acid addition salt thereof is administered as a unit dosage form.  
   
   
       17 . The method of  claim 16 , wherein the unit dosage form is a tablet.  
   
   
       18 . The method of  claim 16 , wherein the unit dosage form in a capsule.  
   
   
       19 . The method of  claim 15 , wherein the method comprises administering 1.0 to 50 mg/day of escitalopram or a pharmaceutically acceptable salt thereof to the patient.  
   
   
       20 . The method of  claim 15 , wherein the method comprises administering 5 to 40 mg/day of escitalopram or a pharmaceutically acceptable salt thereof to the patient.  
   
   
       21 . The method of  claim 15 , wherein the method comprises administering 10 to 20 mg/day of escitalopram or a pharmaceutically acceptable salt thereof to the patient.  
   
   
       22 . The method of  claim 15 , wherein the salt of escitalopram is escitalopram oxalate.  
   
   
       23 . The method of  claim 16 , wherein the salt of escitalopram is escitalopram oxalate.  
   
   
       24 . The method of  claim 17 , wherein the salt of escitalopram is escitalopram oxalate.  
   
   
       25 . The method of  claim 18 , wherein the salt of escitalopram is escitalopram oxalate.  
   
   
       26 . The method of  claim 19 , wherein the salt of escitalopram is escitalopram oxalate.  
   
   
       27 . The method of  claim 20 , wherein the salt of escitalopram is escitalopram oxalate.  
   
   
       28 . The method of  claim 21 , wherein the salt of escitalopram is escitalopram oxalate.